Zurich scholarship: cold stroke in the first exchanges -January 27, 2025 at 09:36

Zurich scholarship: cold stroke in the first exchanges -January 27, 2025 at 09:36
Zurich scholarship: cold stroke in the first exchanges -January 27, 2025 at 09:36

Zurich (AWP) – The Swiss Stock Exchange was enormous on Monday morning, out of a splendor period and at the edge of a week under the sign of the European Central Bank (ECB) on Wednesday and the American Federal Reserve ( Fed) Thursday. The American clues had completed the Friday in the red session, against the backdrop of profits.

The favorable situation since the entry according to Donald Trump in the White House has radically changed on Friday, with the publication of clues of purchasing managers in the United States and Europe, notes Ipek Ozkardeskaya de Swissquote. “These economic indicators, better than expected, have tempered hopes for reducing the Fed rates,” said the Glandoise online bank analyst.

In the cyclical department, China reported a compassionate of its manufacturing activity in January, interrupting three months of convalescence and arousing new fears for the economic health of the Empire of the Middle.

At 09:10 am, the Swiss Market Index (SMI) won from 0.45% to 12,231.97 points, the Swiss Leader Index (SLI) from 0.54% to 2026.83 points and the Swiss Performance Index (SPI) of 0.42% to 16,293.52 points. The resistance offered by the three heavy goods vehicles and five other of the 30 main valuations was not enough to stem access to gloom.

The SGS inspection and certification giant flew by 5.0%, after having ended negotiations with its hexagonal counterpart Veritas around a rapprochement. The Verniolo-Winterthourois chemist of the Givaudan aromas and perfumes (+2.2%) took advantage of a recommendation for the purchase made by JPMorgan, thus ignoring a planing of his course objective by Berenberg.

-

Novartis pharmaceutical juggernaut (+1.0%) was in the head trio, without any particular indication. The other heavyweights Nestlé ( +0.5%) and rock (good +0.4%) also reduced the impact. The other Rhenish Pharmaceutical Béhemoth has praised the effectiveness of the Elevidys partner of the Massachussetais Sarepta partner against Duchenne myopathy.

The Logitech mouse giant (-1.8%) illustrated the access to feverishness that has been shaking technological values ​​since the end of last week. The young Chinese shoot Deepseek presented an artificial intelligence model likely to question the primacy in the matter of American giants, moreover operating on less gourmet chips.

Jh/al

-

--

PREV Bitter victory for the Moulton Hill farm
NEXT What reserves the year 2025 for the big winners of 2024?